Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors Accurate medication reconciliation is ...
Total Point Urgent Care Opens in Nixa, Bringing Advanced Care and TeleVisit Options to the Community
Nixa’s new Total Point Urgent Care offers advanced care, TeleVisit services, and a dedicated team to keep the community healthy. NIXA, MO, UNITED STATES, December 4 ...
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback